Keros Therapeutics Operating Margin Growth & History (KROS)

Keros Therapeutics's operating margin was 27.69% for fiscal 2025.

View full Keros Therapeutics company overview

Keros Therapeutics annual operating margin history

Keros Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-3127.69%+5966.64 pp
20242024-12-31−5,938.96%+106604.75 pp
20232023-12-31−112,543.71%—
20212021-12-31−280.46%—
20192019-12-31−105.63%—

Keros Therapeutics operating margin trends

Between the periods ended 2019-12-31 and 2025-12-31, Keros Therapeutics's operating margin increased from −105.63% to 27.69%, a change of +133.32 percentage points. The latest reported quarter, Q1 2026, shows −7,050.95%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Keros Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about KROS yet. Start the conversation.

Write the first post